Cointelegraph Bitcoin & Ethereum Blockchain News
Is Tether MiCA compliant? The EU's new Markets in Crypto-Assets regulation, better known as MiCA, is the first major attempt by a global economic power to create clear, region-wide rules for the crypto space, and stablecoins are a big focus.MiCA mandates best practices.
Stock Market Is Underpricing 'Downside Risks Of The Tariff Rates,' Warns Expert: Tariff Policy Nuances Are 'Far More Important' Than The 'One Big, Beautiful Bill' - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )
While investors are assessing the potential impacts of the "One Big Beautiful Bill Act," this expert is urging investors to look beyond and consider a more potent market mover - U.S. tariff policy.
Resolutions of the Annual General Meeting of Shareholders of AS Ekspress Grupp held on 23 May 2025
Resolutions of the Annual General Meeting of Shareholders of AS Ekspress Grupp held on 23 May ...
Frontline Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Frontline ( NYSE:FRO )
Frontline plc FRO will release its first-quarter earnings results before the opening bell on Friday, May 23. Analysts expect the Limassol, Cyprus-based company to report quarterly earnings at 23 cents per share, down from 62 cents per share in the year-ago period.
Results of the Votes of the Combined Shareholders' General Meeting of May 22, 2025
Daix ( France ) , New York City ( New York, United States ) , May 23, 2025 - Inventiva ( Euronext Paris and Nasdaq: IVA ) ( the "Company" ) , a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated ...
Results of the Votes of the Combined Shareholders' General Meeting of May 22, 2025 - Inventiva ( OTC:IVEVF ) , Inventiva ( NASDAQ:IVA )
Daix ( France ) , New York City ( New York, United States ) , May 23, 2025 - Inventiva ( Euronext Paris and Nasdaq: IVA ) ( the "Company" ) , a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated ...
